Minor Name Changes in JoVE

JoVE made some minor name changes to their Journal sections and Science Education collections. These changes have been made to assure that these names more accurately reflect the character and content of each section/collection. The following changes became effective on Monday, March 2 and will be reflected across all JoVE platforms in the coming days:

Product Line Old Name New Name
JoVE Journal Applied Physics Engineering
JoVE Journal Clinical & Translational Medicine Medicine
JoVE Science Education Model Organisms I Essentials of Biology I
JoVE Science Education Model Organisms II Essentials of Biology II
Posted in databases, Library Resources | Tagged | Leave a comment

JoVE Goes Mobile

Just the other day, I’m sure you were asking yourself, “What’s new with JoVE?” Well, JoVE has gone mobile.

“New JoVE mobile apps available FREE for your institution!

JoVE has just released two brand new mobile apps and a newly optimized version of the JoVE website that delivers seamless access to content from any mobile device. Researchers can now view JoVE videos on their iPhone, Android, tablet or other mobile device.

With JoVE Mobile, scientists and students alike can now enjoy the rich multimedia experience delivered by JoVE scientific video articles from the mobile device of their choice, anytime and anywhere. As loyal JoVE clients, all members of your institution can download the apps free of charge. To download JoVE Mobile, search for ‘JoVE’ in the Apple app store or on Google Play.”

If you have any questions or comments your friendly neighbourhood librarians at the Talbot Research Library, extension 2711.

Posted in Uncategorized | Leave a comment

Introducing SCOPUS and EMBASE

Talbot Library recently added SCOPUS and EMBASE to our list of databases.

EMBASE is a major index of peer-reviewed literature in the following areas: drug research, pharmacology, pharmaceutics, toxicology, clinical and experimental human medicine, health policy and management, public health, environmental health, psychiatry, biomedical engineering and instrumentation, and some coverage of nursing, psychology, and alternative medicine. Starting in 2009, EMBASE starting indexing conference proceedings as well as journals. It’s a great starting point for research on pharmaceuticals and medical devices. EMBASE itself is not full-text, but it does provide links to full-text articles when available.

SCOPUS is an index of peer-reviewed journals in the life sciences, social sciences, and physical science. In addition, SCOPUS indexes patents, patent citations, pre-prints, conference papers, and trade publications. It complements our existing databases nicely and helps you find elusive grey literature. SCOPUS is not full-text, but it does provide links to full-text articles when available.

Talbot Library is hosting two demos on Thursday, 12 March 2015; a SCOPUS demo will be held in the Lippincott Room at 10am and an EMBASE demo will be held in the Library conference room at 1PM. If you  have any questions, don’t hesitate to phone us at extension 2711.

Posted in databases, Library Resources | Tagged , | Leave a comment

Staff Publications Received in September 2014

Staff Publications Received in September 2014

  1. Anikeeva N, Steblyanko M, Fayngerts S, Kopylova N, Marshall DJ, Powers GD, Sato T, Campbell KS, Sykulev Y. Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. European Journal of Immunology. 2014;44(8):2331-9. Read the article.
  1. Baker NM, Yee Chow H, Chernoff J, Der CJ. Molecular Pathways: Targeting RAC-p21-Activated Serine-Threonine Kinase Signaling in RAS-Driven Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014;20(18):4740-6. PMCID: Pmc4166583. Read the article.
  1. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M. Prostate cancer early detection, version 1.2014. Journal of the National Comprehensive Cancer Network : JNCCN. 2014;12(9):1211-9. Read the article.
  1. Domanitskaya N, Wangari-Talbot J, Jacobs J, Peiffer E, Mahdaviyeh Y, Paulose C, Malofeeva E, Foster K, Cai KQ, Zhou Y, Egleston B, Hopper-Borge E. Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment response. British journal of cancer. 2014;111(4):696-707. Read the article.
  1. Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, Hodi FS, Ibrahim N, Weiss SE, Kelly PJ, Floyd SR, Mahadevan A, Alexander BM. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiation Oncology. 2014;9:9. Read the article.
  1. Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN. Gene Panel Testing for Inherited Cancer Risk. Journal of the National Comprehensive Cancer Network : JNCCN. 2014;12(9):1339-46. Read the article.
  1. Harris D, Patrick-Miller L, Schwartz L, Lantos J, Daugherty C, Daly M, Andrulis IL, Buys SS, Chung WK, Frost CJ, John EM, Keegan THM, Knight JA, Terry MB, Bradbury AR. Human Subjects Protection: An Event Monitoring Committee for Research Studies of Girls From Breast Cancer Families. Journal of Adolescent Health. 2014;55(3):352-7. Read the article.
  1. Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung. 2014;192(5):639-48. Read the article.
  1. Heckman CJ, Darlow S, Kloss JD, Cohen-Filipic J, Manne SL, Munshi T, Yaroch AL, Perlis C. Measurement of tanning dependence. Journal of the European Academy of Dermatology and Venereology. 2014;28(9):1179-85. Read the article.

10. Held-Warmkessel J, Dell DD. Lactic acidosis in patients with cancer.       Clinical journal of oncology nursing. 2014;18(5):592-4. Read the article.

11. Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J, Zhang Y, Yang L, Zhong X, Wang LP, Jean S, Li C, Huang Q, Katsaros D, Montone KT, Tanyi JL, Lu Y, Boyd J, Nathanson KL, Li H, Mills GB, Zhang L. A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer. Cancer cell. 2014;26(3):344-57. PMCID: Pmc4159613. Read the article.

12. Layfield LJ, Ehya H, Filie AC, Hruban RH, Jhala N, Joseph L, Vielh P, Pitman MB. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The Papanicolaou Society of Cytopathology Guidelines. CytoJournal. 2014;11(Suppl 1):4. PMCID: Pmc4153340. Read the article.

13. Lee S, Goldfinger LE. RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells. Faseb Journal. 2014;28(9):4158-68. Read the article.

14. Li X, Zhang D, Yang J, Liu B. A study of the short- to long-phantom dose ratios for CT scanning without table translation. Medical physics. 2014;41(9):091912. Read the article.

15. McAdams F, Martin V. Incorporating breast cancer care data into clinical assessment. Clinical journal of oncology nursing. 2014;18(0):25-6. Read the article.

16. McCleary NJ, Dotan E, Browner I. Refining the Chemotherapy Approach for Older Patients With Colon Cancer. Journal of Clinical Oncology. 2014;32(24):2570-80. Read the article.

17. Moul JW, Chen DYT, Trabulsi EJ, Warlick CA, Ruckle HC, Porter JR, Yoshida JS, Adams GW, Kella N, Matsunaga GS, Bans LL, Sarno MJ, McDermed JE, Triebe MT, Reynolds MA, ProsVue Field Experience T. Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy. Prostate Cancer and Prostatic Diseases. 2014;17(3):280-5. Read the article.

18. Murad FM, Banerjee S, Barth BA, Bhat YM, Chauhan SS, Gottlieb KT, Konda V, Maple JT, Pfau P, Pleskow D, Siddiqui UD, Tokar JL, Wang A, Rodriguez SA. Image management systems. Gastrointestinal endoscopy. 2014;79(1):15-22. Read the article.

19. Nikonova AS, Plotnikova OV, Serzhanova V, Efimov A, Bogush I, Cai KQ, Hensley HH, Egleston BL, Klein-Szanto A, Seeger-Nukpezah T, Golemis EA. Nedd9 restrains renal cystogenesis in Pkd1(-/-) mice. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(35):12859-64. Read the article.

20. Ragin C, Park JY. Biospecimens, biobanking and global cancer research collaborations. Ecancermedicalscience. 2014;8:454. PMCID: Pmc4154946. Read the article.

21. Raman JD, Lin YK, Kaag M, Atkinson T, Crispen P, Wille M, Smith N, Hockenberry M, Guzzo T, Peyronnet B, Bensalah K, Simhan J, Kutikov A, Cha E, Herman M, Scherr D, Shariat SF, Boorjian SA. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urologic oncology. 2014;32(1):47.e9-14. Read the article.

22. Siciliano NA, Hersperger AR, Lacuanan AM, Xu RH, Sidney J, Sette A, Sigal LJ, Eisenlohr LC. Impact of Distinct Poxvirus Infections on the Specificities and Functionalities of CD4(+) T Cell Responses. Journal of Virology. 2014;88(17):10078-91. Read the article.

23. Siddiqui UD, Barth BA, Banerjee S, Bhat YM, Chauhan SS, Gottlieb KT, Konda V, Maple JT, Murad FM, Pfau P, Pleskow D, Tokar JL, Wang A, Rodriguez SA. Devices for the endoscopic treatment of hemorrhoids. Gastrointestinal endoscopy. 2014;79(1):8-14. Read the article.

24. Simhan J, Smaldone MC, Egleston BL, Canter D, Sterious SN, Corcoran AT, Ginzburg S, Uzzo RG, Kutikov A. Nephron-sparing management vs radical nephroureterectomy for low-or moderate-grade, low-stage upper tract urothelial carcinoma. BJU international. 2014;114(2):216-20. Read the article.

25. Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in the treatment of angiosarcoma: a single institution experience. American journal of surgery. 2014;208(2):254-9. Read the article.

26. Stump TK, Eghan N, Egleston BL, Hamilton O, Pirollo M, Schwartz JS, Armstrong K, Beck JR, Meropol NJ, Wong YN. Cost concerns of patients with cancer. Journal of oncology practice / American Society of Clinical Oncology. 2013;9(5):251-7. PMCID: Pmc3770507. Read the article.

27. Tomaszewski JJ, Smaldone MC, Cung B, Li T, Mehrazin R, Kutikov A, Canter DJ, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology. 2014;84(2):351-7. PMCID: Pmc4115009. Read the article.

28. Tomaszewski JJ, Smaldone MC, Mehrazin R, Kocher N, Ito T, Abbosh P, Baber J, Kutikov A, Viterbo R, Chen DY, Canter DJ, Uzzo RG. Anatomic complexity quantitated by nephrometry score is associated with prolonged warm ischemia time during robotic partial nephrectomy. Urology. 2014;84(2):340-4. PMCID: Pmc4114993. Read the article.

29. Wang XY, Wang JM, Zheng H, Xie MY, Hopewell EL, Albrecht RA, Nogusa S, Garcia-Sastre A, Balachandran S, Beg AA. Differential Requirement for the IKK beta/NF-kappa B Signaling Module in Regulating TLR- versus RLR-Induced Type 1 IFN Expression in Dendritic Cells. Journal of Immunology. 2014;193(5):2538-45. Read the article.

30. Xu JF, Kadariya Y, Cheung M, Pei JM, Talarchek J, Sementino E, Tan YF, Menges CW, Cai KQ, Litwin S, Peng HZ, Karar J, Rauscher FJ, Testa JR. Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma. Cancer Research. 2014;74(16):4388-97. Read the article.

31. Xu Q, Hanna G, Grimm J, Kubicek G, Pahlajani N, Asbell S, Fan J, Chen Y, LaCouture T. Quantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy. International journal of radiation oncology, biology, physics. 2014;90(1):94-101. Read the article.

32. Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 2014;13(5):456-64. Read the article.

Posted in Uncategorized | Leave a comment

Staff Publications Received in August 2014

Staff Publications Received in August 2014

  1. Argiris A, Li S, Ghebremichael M, Egloff AM, Wang L, Forastiere AA, Burtness B, Mehra R. Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials. Annals of Oncology. 2014;25(7):1410-6. Read the article.
  1. Beeharry N, Banina E, Hittle J, Skobeleva N, Khazak V, Deacon S, Andrake M, Egleston BL, Peterson JR, Astsaturov I, Yen TJ. Re-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpoints. Cell Cycle. 2014;13(14):2172-91. Read the article.
  1. Behrend SW. New guidelines for chemotherapy-induced peripheral neuropathy. Oncology nursing forum. 2014;41(5):559-60. Read the article.
  1. Benson AB, D’Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H. Hepatobiliary Cancers, Version 2.2014. Journal of the National Comprehensive Cancer Network. 2014;12(8):1152-82. Read the article.
  1. Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass DA. Colon Cancer, Version 3.2014. Journal of the National Comprehensive Cancer Network. 2014;12(7):1028-59. Read the article.
  1. Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, Bruner DW, Movsas B. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. Journal of the National Cancer Institute. 2014;106(7). Read the article.
  1. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O’Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. Survivorship: Immunizations and Prevention of Infections, Version 2.2014. Journal of the National Comprehensive Cancer Network. 2014;12(8):1098-111. Read the article.
  1. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O’Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. Survivorship: Cognitive Function, Version 1.2014. Journal of the National Comprehensive Cancer Network. 2014;12(7):976-86. Read the article.
  1. Doss M. Radiation dose justification and optimization should not be applied to medical imaging in emergency medicine. [letter] Annals of emergency medicine. 2014;64(3):332-3. Read the article.

10. Esse R, Imbard A, Florindo C, Gupta S, Quinlivan EP, Davids M, Teerlink T, de Almeida IT, Kruger WD, Blom HJ, Castro R. Protein arginine hypomethylation in a mouse model of cystathionine beta-synthase deficiency. Faseb Journal. 2014;28(6):2686-95. Read the article.

11. Evens AM, Smith MR, Lossos IS, Helenowski I, Millenson M, Winter JN, Rosen ST, Gordon LI. Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study. British Journal of Haematology. 2014;166(4):514-20. Read the article.

12. Eytan E, Wang K, Miniowitz-Shemtov S, Sitry-Shevah D, Kaisari S, Yen TJ, Liu ST, Hershko A. Disassembly of mitotic checkpoint complexes by the joint action of the AAA-ATPase TRIP13 and p31comet. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(33):12019-24. Read the article.

13. Fadini GP, Ferraro F, Quaini F, Asahara T, Madeddu P. Concise Review: Diabetes, the Bone Marrow Niche, and Impaired Vascular Regeneration. Stem Cells Translational Medicine. 2014;3(8):949-57. Read the article.

14. Fang CY, Egleston BL, Ridge JA, Lango MN, Bovbjerg DH, Studts JL, Burtness BA, Einarson MB, Klein-Szanto AJP. Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2014;36(8):1113-9. Read the article

15. Freedman GM, Fowble BL, Li TY, Hwang ES, Schechter N, Devarajan K, Anderson PR, Sigurdson ER, Goldstein LJ, Bleicher RJ. Risk of Positive Nonsentinel Nodes in Women with 1-2 Positive Sentinel Nodes Related to Age and Molecular Subtype Approximated by Receptor Status. Breast Journal. 2014;20(4):358-63. Read the article.

16. Friedberg JW, Unger JM, Burack WR, Gopal AK, Raju RN, Nademanee AP, Kaminski MS, Li HL, Press OW, Miller TP, Fisher RI. R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433. British Journal of Haematology. 2014;166(3):382-9. Read the article.

 17. Haggerty AF, Hagemann AR, Chu C, Siegelman ES, Rubin SC. Correlation of pelvic magnetic resonance imaging diagnosis with pathology for indeterminate adnexal masses. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2014;24(7):1215-21. Read the article.

18. Heckman CJ, Cohen-Filipic J, Darlow S, Kloss JD, Manne SL, Munshi T. Psychiatric and addictive symptoms of young adult female indoor tanners. American Journal of Health Promotion. 2014;28(3):168-74. Read the article.

19. Held-Warmkessel J. Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Oncology nursing forum. 2014;41(5):551-3. Read the article.

20. Hossain M. Output trends, characteristics, and measurements of three megavoltage radiotherapy linear accelerators. Journal of Applied Clinical Medical Physics. 2014;15(4):137-51. Read the article.

21. Langer CJ, Novello S, Park K, Krzakowski M, Karp DD, Mok T, Benner RJ, Scranton JR, Olszanski AJ, Jassem J. Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(19):2059-66. PMCID: Pmc4067944.

22. Lundy MG, Forman A, Valverde K, Kessler L. An Investigation of Genetic Counselors’ Testing Recommendations: Pedigree Analysis and the Use of Multiplex Breast Cancer Panel Testing. Journal of Genetic Counseling. 2014;23(4):618-32. Read the article.

23. Manne SL, Siegel S, Kashy D, Heckman CJ. Cancer-specific relationship awareness, relationship communication, and intimacy among couples coping with early-stage breast cancer. Journal of Social and Personal Relationships. 2014;31(3):314-34. Read the article.

24. Martin JM, Handorf EA, Kutikov A, Uzzo RG, Bekelman JE, Horwitz EM, Smaldone MC. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 2014;120(14):2114-21. Read the article.

25. Nikonova AS, Gaponova AV, Kudinov AE, Golemis EA. CAS Proteins in Health and Disease: An Update. Iubmb Life. 2014;66(6):387-95. Read the article.

26. Pfeffer LM, Li K, Fleckenstein JF, Marion TN, Diament J, Yang CH, Pfeffer SR, Fan M, Handorf E, Handorf CR. An interferon response gene signature is associated with the therapeutic response of hepatitis C patients. PloS one. 2014;9(8):e104202. PMCID: Pmc4128657. Read the article.

27. Placke T, Faber K, Nonami A, Putwain SL, Salih HR, Heidel FH, Kramer A, Root DE, Barbie DA, Krivtsov AV, Armstrong SA, Hahn WC, Huntly BJ, Sykes SM, Milsom MD, Scholl C, Frohling S. Requirement for CDK6 in MLL-rearranged acute myeloid leukemia. Blood. 2014;124(1):13-23. Read the article.

28. Reis BS, Hoytema van Konijnenburg DP, Grivennikov SI, Mucida D. Transcription Factor T-bet Regulates Intraepithelial Lymphocyte Functional Maturation. Immunity. 2014;41(2):244-56. Read the article.

29. Silver L, Michael JV, Goldfinger LE, Gallo G. Activation of PI3K and R-Ras Signaling Promotes the Extension of Sensory Axons on Inhibitory Chondroitin Sulfate Proteoglycans. Developmental Neurobiology. 2014;74(9):918-33. Read the article.

30. Tejani MA, Ter Veer A, Milne D, Ottesen R, Bekaii-Saab T, Benson AB, 3rd, Schrag D, Shibata S, Skibber J, Weiser M, Wilkinson N, Cohen SJ. Systemic Therapy for Advanced Appendiceal Adenocarcinoma: An Analysis From the NCCN Oncology Outcomes Database for Colorectal Cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2014;12(8):1123-30. Read the article.

31. Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri M, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA. Pancreatic Adenocarcinoma, Version 2.2014 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2014;12(8):1083-93. Read the article.

32. Vibhakar D, Reddy S, Morgan-Hazelwood W, Chang EI. Chimeric pedicled latissimus dorsi flap with lateral thoracic lymph nodes for breast reconstruction and lymphedema treatment in a hypercoagulable patient. Plastic and reconstructive surgery. [letter]2014;134(3):494e-5e. Read the article.

33. Vijayvergia N, Mehra R. Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology. 2014;74(3):437-46. Read the article.

34. Wen KY, Fang CY, Ma GX. Breast cancer experience and survivorship among Asian Americans: a systematic review. Journal of Cancer Survivorship. 2014;8(1):94-107. Read the article.

35. Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA, Plimack ER, Koppie TM, McConkey DJ, Dinney CP, Hoffman VA, Droller MJ, Messing E, Kamat AM. Micropapillary bladder cancer: Current treatment patterns and review of the literature. Urologic Oncology-Seminars and Original Investigations. 2014;32(6):826-32. Read the article.

Posted in Uncategorized | Leave a comment

Staff Publications Received in July 2014

Staff Publications Received in July 2014

  1. Boyd J. Genetic predisposition to breast cancer: the next chapters. Cancer. 2014;120(7):932-4. Read the article.

2.         Brusilovsky M, Radinsky O, Yossef R, Campbell KS, Porgador A. Carbohydrate-mediated modulation of NK cell receptor function: structural and functional influences of heparan sulfate moieties expressed on NK cell surface. Frontiers in oncology. 2014;4:185. PMCID: Pmc4100077. Read the article.

  1. Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(12):1210-7. PMCID: Pmc3986384. Read the article.
  1. Cohen SJ, Konski AA, Putnam S, Ball DS, Meyer JE, Yu JQ, Astsaturov I, Marlow C, Dickens A, Cade DN, Meropol NJ. Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer. British journal of cancer. 2014;111(2):265-71. PMCID: Pmc4102951. Read the article.
  1. Cole M, Parajuli S, Laske D, Goldstein L, Morrison T, Mukherjee A, Tumelty K, Tetzlaff E, von Mehren M, Inniss S. Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer. The American journal of case reports. 2014;15:294-9. PMCID: Pmc4102603. Read the article.
  1. Doss M. CT Radiation Dose Optimization Is Not Advisable in View of Current Knowledge. Journal of the American College of Radiology : JACR. 2014;11(7):745-6. Read the article.
  1. Doss M, Egleston BL, Litwin S. Atomic Bomb Survivor Cataract Surgery Prevalence Data are Consistent with Non-zero Threshold Dose-Comment on Article by Nakashima et al. 2013. Health physics. 2014;107(3):262-3. PMCID: Pmc4123214. [Comment]. Read the article.
  1. Doss M, Little MP, Orton CG. Point/Counterpoint: Low-dose radiation is beneficial, not harmful. Medical physics. 2014;41(7):070601. Read the article.

9.  Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA. Occult primary, version 3.2014. Journal of the National Comprehensive Cancer Network : JNCCN. 2014;12(7):969-74. Read the article.

10. Fang CY, Ross EA, Pathak HB, Godwin AK, Tseng M. Acculturative Stress and Inflammation Among Chinese Immigrant Women. Psychosomatic Medicine. 2014;76(5):320-6. Read the article.

11. Fleisher L, Ruggieri DG, Miller SM, Manne S, Albrecht T, Buzaglo J, Collins MA, Katz M, Kinzy TG, Liu T, Manning C, Charap ES, Millard J, Miller DM, Poole D, Raivitch S, Roach N, Ross EA, Meropol NJ. Application of best practice approaches for designing decision support tools: The preparatory education about clinical trials (PRE-ACT) study. Patient Education and Counseling. 2014;96(1):63-71. Read the article.

12.       Halliday D, Butler R, Francis D, Thompson J, Joseph M, Ragin CC. Knowledge and Attitudes toward HPV and the HPV Vaccines in The Bahamas. The West Indian medical journal. 2013;62(8):731-7. Read the article.

13. Hensley H, Devarajan K, Johnson JR, Piwnica-Worms D, Godwin AK, von Mehren M, Rink L. Evaluating new therapies in gastrointestinal stromal tumor using in vivo molecular optical imaging. Cancer Biology & Therapy. 2014;15(7):911-8. Read the article.

14.       Herrera AF, Crosby-Thompson A, Friedberg JW, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Millenson MM, Nademanee AP, Niland JC, Rodig SJ, Rodriguez MA, Zelenetz AD, LaCasce AS. Comparison of Referring and Final Pathology for Patients With T-Cell Lymphoma in the National Comprehensive Cancer Network. Cancer. 2014;120(13):1993-9. Read the article.

15.       Hu W, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, Luo B, Alvarez-Carbonell D, Garcia-Mesa Y, Karn J, Mo X, Khalili K. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(31):11461-6. Read the article.

16.       Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. Journal of the National Cancer Institute. 2014;106(5). PMCID: Pmc4112926. Read the article.

17. Lodhi N, Kossenkov AV, Tulin AV. Bookmarking promoters in mitotic chromatin: poly(ADP-ribose)polymerase-1 as an epigenetic mark. Nucleic Acids Research. 2014;42(11):7028-38. Read the article.

18. Longacre ML, Ross EA, Fang CY. Caregiving Choice and Emotional Stress Among Cancer Caregivers. Western Journal of Nursing Research. 2014;36(6):806-24. Read the article.

19. Mantia-Smaldone G, Ronner L, Blair A, Gamerman V, Morse C, Orsulic S, Rubin S, Gimotty P, Adams S. The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1–deficient ovarian tumors and can be exploited to improve treatment response in a mouse model. Gynecologic oncology. 2014;133(3):584-90. Read the article.

20. Mehra R, Zhu F, Yang DH, Cai KQ, Weaver J, Singh MK, Nikonova AS, Golemis EA, Flieder DB, Cooper HS, Lango M, Ridge JA, Burtness B. Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013;19(23):6633-43. PMCID: Pmc4045641. Read the article.

21. Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. Journal of gastrointestinal cancer. 2013;44(4):450-5. PMCID: Pmc3963822. Read the article.

22. Min H, Ohira R, Collins MA, Bondy J, Avis NE, Tchuvatkina O, Courtney PK, Moser RP, Shaikh AR, Hesse BW, Cooper M, Reeves D, Lanese B, Helba C, Miller SM, Ross EA. Sharing behavioral data through a grid infrastructure using data standards. Journal of the American Medical Informatics Association. 2014;21(4):642-9. Read the article.

23.       Park DJ, Tao K, Le Calvez-Kelm F, Nguyen-Dumont T, Robinot N, Hammet F, Odefrey F, Tsimiklis H, Teo ZL, Thingholm LB, Young EL, Voegele C, Lonie A, Pope BJ, Roane TC, Bell R, Hu H, Shankaracharya, Huff CD, Ellis J, Li J, Makunin IV, John EM, Andrulis IL, Terry MB, Daly M, Buys SS, Snyder C, Lynch HT, Devilee P, Giles GG, Hopper JL, Feng BJ, Lesueur F, Tavtigian SV, Southey MC, Goldgar DE. Rare Mutations in RINT1 Predispose Carriers to Breast and Lynch Syndrome-Spectrum Cancers. Cancer discovery. 2014;4(7):804-15. Read the article.

24. Patel SA, Sandberg LJ, Ranganath B, Devarajan K, Toto J, Topham NS. Impact of Adjuvant Chemotherapy on Abdominal Wall Hernias and Bulges After Muscle-Sparing Free TRAM Flaps for Breast Reconstruction. Annals of Plastic Surgery. 2014;73(1):62-7. Read the article.

25. Pimtong W, Datta M, Ulrich AM, Rhodes J. Drl.3 governs primitive hematopoiesis in zebrafish. Scientific reports. 2014;4:5791. Read the article.

26. Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DYT, Lallas CD, Wong YN, Lin JQ, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity. Journal of Clinical Oncology. 2014;32(18):1895-901. Read the article.

27. Poleshko A, Katz RA. Specifying peripheral heterochromatin during nuclear lamina reassembly. Nucleus-Austin. 2014;5(1):32-9. Read the article.

28. Ragin C, Obikoya-Malomo M, Kim S, Chen ZJ, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, Spandidos DA, Gorgoulis V, Heideman DAM, van Boerdonk RAA, Hiroshima K, Iwakawa R, Kastrinakis NG, Kinoshita I, Akiba S, Landi MT, Liu HE, Wang JL, Mehra R, Khuri FR, Lim WT, Owonikoko TK, Ramalingam S, Sarchianaki E, Syrjanen K, Tsao MS, Sykes J, Hee SW, Yokota J, Zaravinos A, Taioli E. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis. 2014;35(6):1267-75. Read the article.

29. Seeger-Nukpezah T, Little JL, Serzhanova V, Golemis EA. Cilia and cilia-associated proteins in cancer. Drug discovery today Disease mechanisms. 2013;10(3-4):e135-e42. PMCID: Pmc4073101. Read the article.

30.       Shah NR, Tancioni I, Ward KK, Lawson C, Chen XL, Jean C, Sulzmaier FJ, Uryu S, Miller NLG, Connolly DC, Schlaepfer DD. Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer. Gynecologic oncology. 2014;134(1):104-11. Read the article.

31. Tetzlaff ED, Davey MP. Optimizing adherence to adjuvant imatinib in gastrointestinal stromal tumor. Journal of the advanced practitioner in oncology. 2013;4(4):238-50. PMCID: Pmc4093429. Read the article.

32.       Trotti A, 3rd, Zhang Q, Bentzen SM, Emami B, Hammond ME, Jones CU, Morrison WH, Sagar SM, Ridge JA, Fu KK, Ang KK. Randomized Trial of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord (RTOG 9512). International journal of radiation oncology, biology, physics. 2014;89(5):958-63. Read the article.

33.       Tu YF, Hershman DL, Bhalla K, Fiskus W, Pellegrino CM, Andreopoulou E, Makower D, Kalinsky K, Fehn K, Fineberg S, Negassa A, Montgomery LL, Wiechmann LS, Alpaugh RK, Huang M, Sparano JA. A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Research and Treatment. 2014;146(1):145-52. Read the article.

34.       Wang DS, Patel A, Shukla S, Zhang YK, Wang YJ, Kathawala RJ, Robey RW, Zhang L, Yang DH, Talele TT, Bates SE, Ambudkar SV, Xu RH, Chen ZS. Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2. Oncotarget. 2014;5(12):4529-42. Read the article.

35.       Wu HC, Wang Q, Chung WK, Andrulis IL, Daly MB, John EM, Keegan THM, Knight J, Bradbury AR, Kappil MA, Gurvich I, Santella RM, Terry MB. Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study. Epigenetics. 2014;9(7):929-33. Read the article.

36. Zaorsky NG, Doyle LA, Hurwitz MD, Dicker AP, Den RB. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer? Expert Review of Anticancer Therapy. 2014;14(1):39-50. Read the article.

37.       Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Sokol L, Swinnen LJ, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H. Non-Hodgkin’s Lymphomas, Version 2.2014. Journal of the National Comprehensive Cancer Network. 2014;12(6):916-45. Read the article.

Posted in Uncategorized | Leave a comment

Staff Publications Received in June 2014

Staff Publications Received in June 2014

1.         Behrend SW. Survivorship care plans. Oncology nursing forum, 41(4):447-8, 2014. Read the article.

2.         Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Ho AL, Lewis KD, Lydiatt DD, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Perlis CS, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Werchniak AE, Wong SL, Zic JA, McMillian N, Hoffman K, Ho M. Dermatofibrosarcoma protuberans, version 1.2014. Journal of the National Comprehensive Cancer Network : JNCCN, 12(6):863-8, 2014. Read the article.

3.         Bilusic M, Wong YN. Anti-angiogenesis in prostate cancer: knocked down but not out. Asian J Androl, 16(3):372-7, 2014. Read the article.

4.         Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study. J Clin Oncol, 32(12):1210-7, 2014. Read the article.

5.         Carlson RW, Larsen JK, McClure J, Fitzgerald L, Venook AP, Benson AB, Anderson BO. International Adaptations of NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw, 12(5):643-8, 2014. Read the article.

6.         Chen DYT, Uzzo RG, Viterbo R. Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death. World J Urol, 32(3):607-13, 2014. Read the article.

7.         Chiang YT, Ip W, Shao W, Song ZE, Chernoff J, Jin T. Activation of cAMP signaling attenuates impaired hepatic glucose disposal in aged male p21-activated protein kinase-1 knockout mice. Endocrinology, 155(6):2122-32, 2014. Read the article.

8.         Chisari FV, Mason WS, Seeger C. Virology. Comment on “Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA”. Science (New York, NY), 344(6189):1237, 2014. Read the article.

9.         Coit DG, Thompson JA, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daniels GA, Daud A, DiMaio D, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi S, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Martini MC, Olszanski AJ, Ross MI, Salama A, Swetter SM, Tanabe KK, Trisal V, Urist MM, McMillian NR, Ho M. Melanoma, Version 4.2014 Featured Updates to the NCCN Guidelines. J Natl Compr Cancer Netw, 12(5):621-9, 2014. Read the article.

10.        Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PWT, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP. Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial. J Clin Oncol, 32(15):1563-70, 2014. Read the article.

11.        Dell DD, Held-Warmkessel J, Jakubek P, O’Mara T. Care of the open abdomen after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies. Oncology nursing forum, 41(4):438-41, 2014. [Comment] Read the article.

12.        Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, Cheng JD, Alpaugh RK, Cooper H, Wright JJ, Cohen SJ. A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers. Clin Colorectal Canc, 13(2):81-6, 2014. Read the article.

13.        Doss M. Low dose radiation adaptive protection to control neurodegenerative diseases. Dose-response : a publication of International Hormesis Society, 12(2):277-87, 2014. Pmc4036399. Read the article.

14.        Doss M. Correcting systemic deficiencies in our scientific infrastructure. Dose-response : a publication of International Hormesis Society, 12(2):185-201, 2014. Pmc4036394. Read the article.

15.        Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu YH, Schwartz JD, Thompson JA. A Phase 2, Single-Arm Study of Ramucirumab in Patients With Metastatic Renal Cell Carcinoma With Disease Progression on or Intolerance to Tyrosine Kinase Inhibitor Therapy. Cancer, 120(11):1647-55, 2014. Read the article.

16.        Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Cancer biology & therapy, 15(3):329-41, 2014. Read the article.

17.        Gustafson HL, Yao S, Goldman BH, Lee K, Spier CM, LeBlanc ML, Rimsza LM, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Slager SL, Persky DO, Miller TP, Fisher RI, Ambrosone CB, Briehl MM. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma. Am J Hematol, 89(6):639-45, 2014. Read the article.

18.        Hakanson M, Cukierman E, Charnley M. Miniaturized pre-clinical cancer models as research and diagnostic tools. Adv Drug Deliv Rev, 69:52-66, 2014. Read the article.

19.        Hall MJ. Conflicted confidence: academic oncologists’ views on multiplex pharmacogenomic testing. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(13):1290-2, 2014. Read the article.

20.        Handorf E, Crumpler N, Gross L, Giri VN. Prevalence of the HOXB13 G84E Mutation Among Unaffected Men with a Family History of Prostate Cancer. J Genet Couns, 23(3):371-6, 2014. Read the article.

21.        Haugh KA, Shalginskikh N, Nogusa S, Skalka AM, Katz RA, Balachandran S. The interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus. Virology journal, 11(1):100, 2014. Pmc4049388. Read the article.

22.        Heckman CJ. Enhancing skin cancer screening through behavioral intervention. JAMA dermatology, 150(4):363-5, 2014. Pmc3984595. Read the article.

23.        Johnson ME, Robu VG, Turaka A. Nasopharyngeal Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(11):e40-1, 2014. [Case Report]. Read the article.

24.        Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM, Perlis CS, Turaka A. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma. Journal of the American Academy of Dermatology, 70(6):1028-35, 2014. Read the article.

25.        Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang CZ, Sundararajan A, Guo HY, Roback L, Speck SH, Bertin J, Gough PJ, Balachandran S, Mocarski ES. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci U S A, 111(21):7753-8, 2014. Read the article.

26.        Kang SW, Lang JY, Wang P, Li J, Lin MH, Chen XM, Guo M, Chen F, Chen LL, Ma CM. Optimization strategies for pulsed low-dose-rate IMRT of recurrent lung and head and neck cancers. J Appl Clin Med Phys, 15(3):102-13, 2014. Read the article.

27.        Kim SP, Gross CP, Nguyen PL, Smaldone MC, Shah ND, Karnes RJ, Thompson RH, Han LC, Yu JB, Trinh QD, Ziegenfuss JY, Sun M, Tilburt JC. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Medical care, 52(7):579-85, 2014. Read the article.

28.        Kim SP, Gross CP, Nguyen PY, Smaldone MC, Thompson RH, Shah ND, Kutikov A, Han LC, Karnes RJ, Ziegenfuss JY, Tilburt JC. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate cancer and prostatic diseases, 17(2):163-9, 2014. Read the article.

29.        Langer CJ, Novello S, Park K, Krzakowski M, Karp DD, Mok T, Benner RJ, Scranton JR, Olszanski AJ, Jassem J. Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(19):2059-66, 2014. Read the article.

30.        Levy MH. Palliative care and oncology: integration leads to better care. Oncology (Williston Park, NY), 25(13):1275, 2011. Read the article.

31.        Mahadevan D, Morales C, Cooke LS, Manziello A, Mount DW, Persky DO, Fisher RI, Miller TP, Qi W. Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2. PloS one, 9(6):e95184, 2014. Pmc4043492. Read the article.

32.        Manne S, Kashy D, Albrecht T, Wong YN, Flamm AL, Benson AB, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJ. Knowledge, Attitudes, and Self-efficacy as Predictors of Preparedness for Oncology Clinical Trials: A Mediational Model. Med Decis Mak, 34(4):454-63, 2014. Read the article.

33.        Marur S, Burtness B. Oropharyngeal squamous cell carcinoma treatment: current standards and future directions. Curr Opin Oncol, 26(3):252-8, 2014. Read the article.

34.        Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, Rohren E, Rosenfeld S, Schaeffer E, Small EJ, Sonpavde G, Srinivas S, Stein C, Strope SA, Tward J, Shead DA, Ho M. Prostate Cancer, Version 2.2014. J Natl Compr Cancer Netw, 12(5):686-718, 2014. Read the article.

35.        Mookerjee-Basu J, Kappes DJ. New ingredients for brewing CD4(+)T (cells): TCF-1 and LEF-1. Nature immunology, 15(7):593-4, 2014. [comment]. Read the article.

36.        Pape-Zambito D, Jiang Z, Wu H, Devarajan K, Slater CM, Cai KQ, Patchefsky A, Daly MB, Chen X. Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients. PloS one, 9(6):e100488, 2014. Pmc4076240.  Read the article.

37.        Perkins J, Boland P, Cohen SJ, Olszanski AJ, Zhou Y, Engstrom P, Astsaturov I. Successful Imatinib Therapy for Neuroendocrine Carcinoma With Activating KIT Mutation: A Case Study. Journal of the National Comprehensive Cancer Network : JNCCN, 12(6):847-52, 2014. Read the article.

38.        Prebet T, Sun ZX, Figueroa ME, Ketterling R, Melnick A, Greenberg PL, Herman J, Juckett M, Smith MR, Malick L, Paietta E, Czader M, Litzow M, Gabrilove J, Erba HP, Gore SD, Tallman MS. Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905. J Clin Oncol, 32(12):1242-8, 2014. Read the article.

39.        Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang-Claude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P, Konstanta I, Kotoula V, Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G, Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP, Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold C, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek VL, Sicotte H, Prodduturi N, Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma VM, Fischer HP, Reed MWR, Cross SS, Deming-Halverson S, Shrubsole M, Cai QY, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rudiger T, Wolfing H, Ulmer HU, Forsti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkila P, Aittomaki K, Blomqvist C, Irwanto A, Liu JJ, Pankratz VS, Wang XS, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Fergus J, Network G. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis, 35(5):1012-9, 2014. Read the article.

40.        Sears HF. Remembrances of Hilary Koprowski from a Surgeon’s Perspective. Monoclonal antibodies in immunodiagnosis and immunotherapy, 33(3):173-6, 2014. Pmc4066234. Read the article.

41.        Shapovalov MV, Wang Q, Xu Q, Andrake M, Dunbrack RL, Jr. BioAssemblyModeler (BAM): User-Friendly Homology Modeling of Protein Homo- and Heterooligomers. PloS one, 9(6):e98309, 2014. Pmc4055448. Read the article.

42.        Simon MA, de la Riva EE, Bergan R, Norbeck C, McKoy JM, Kulesza P, Dong XQ, Schink J, Fleisher L. Improving Diversity in Cancer Research Trials: The Story of the Cancer Disparities Research Network. J Cancer Educ, 29(2):366-74, 2014. Read the article.

43.        Socol Y, Dobrzynski L, Doss M, Feinendegen LE, Janiak MK, Miller ML, Sanders CL, Scott BR, Ulsh B, Vaiserman A. Commentary: ethical issues of current health-protection policies on low-dose ionizing radiation. Dose-response : a publication of International Hormesis Society, 12(2):342-8, 2014. Pmc4036401. Read the article.

44.        Virtue SM, Manne SL, Ozga M, Kissane DW, Rubin S, Heckman C, Rosenblum N, Graff JJ. Cancer-Related Concerns Among Women With a New Diagnosis of Gynecological Cancer An Exploration of Age Group Differences. Int J Gynecol Cancer, 24(1):165-71, 2014. Read the article.

45.        von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, 3rd, DeLaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, 3rd, Mayerson J, McGarry SV, Meyer C, O’Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H. Gastrointestinal stromal tumors, version 2.2014. Journal of the National Comprehensive Cancer Network : JNCCN, 12(6):853-62, 2014. Read the article.

46.        Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Med Dosim, 39(2):185-9, 2014. Read the article.

47.        Zhang H, Chang YC, Brennan ML, Wu JH. The structure of Rap1 in complex with RIAM reveals specificity determinants and recruitment mechanism. J Mol Cell Biol, 6(2):128-39, 2014. Read the article.

48.        Zhou Z, Sehn LH, Rademaker AW, Gordon LI, LaCasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood, 123(6):837-42, 2014. Read the article.

49.        Zibelman M, Xiang Q, Muchka S, Nickoloff S, Marks S. Assessing prognostic documentation and accuracy among palliative care clinicians. Journal of palliative medicine, 17(5):521-6, 2014. Read the article.

 

Posted in Uncategorized | Leave a comment